Lawmaker asks DoH to fast-track cancer fund rules

A LAWMAKER urged the Department of Health (DoH) to fast-track the guidelines on how cancer patients can avail themselves of a P620-million government fund.

In a statement Tuesday, Quezon City Rep. Alfredo Paolo “Alfred” D. Vargas III said the rules under Republic Act 11215 or the National Integrated Cancer Control Act (NICCA) would help Filipino cancer patients who have a hard time paying for treatment.

“Your favorable support for the proper implementation of NICCA, particularly the cancer assistance fund, will institutionalize the government’s support and protection for families who are heavily affected by this public health emergency,” he said.

Mr. Vargas said he asked Health authorities about the status of the guidelines last year. The agency is drafting an administrative order on the fund’s implementation, he added.

The cancer assistance fund will be made available to cancer patients in public and private care centers licensed  by the Health department.

Mr. Vargas said both DoH and the Philippine Health Insurance Corp, need to consult stakeholders about how they can avail themselves of the fund. — Gillian M. Cortez

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

Your daily news source covering investing ideas, market stocks, business, retirement tips from Wall St. to Silicon Valley.

Disclaimer:, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 TheProficientInvestor. All Rights Reserved.

To Top

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!